z-logo
open-access-imgOpen Access
Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis
Author(s) -
Francesca Conradie,
Tatevik R. Bagdasaryan,
Borisov Se,
Pauline Howell,
Lali Mikiashvili,
Nosipho Ngubane,
Anastasia Samoilova,
Sergey Skornykova,
Elena Tudor,
Ebrahim Variava,
P. K. Yаblonskiy,
Daniel E. Everitt,
Genevieve H. Wills,
Eugene Sun,
Morounfolu Olugbosi,
Erica Egizi,
Mengchun Li,
Alda Holsta,
Juliano Timm,
Matthew Bates,
Angela M. Crook,
Stella M. Fabiane,
Robert Hunt,
Timothy D. McHugh,
Conor Tweed,
Salah Foraida,
Carl M. Mendel,
Melvin Spigelman
Publication year - 2022
Publication title -
new england journal of medicine
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa2119430
Subject(s) - bedaquiline , linezolid , tuberculosis , medicine , drug , intensive care medicine , pharmacology , mycobacterium tuberculosis , biology , pathology , bacteria , staphylococcus aureus , vancomycin , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom